Cargando…

Effects of 0.01% Atropine Instillation Assessed Using Swept-Source Anterior Segment Optical Coherence Tomography

In this paper, we assessed the short-term effects of 0.01% atropine eye drops on anterior segment parameters by performing ocular biometry using a swept-source anterior segment optical coherence tomography system (AS-OCT). We recruited 17 healthy volunteers (10 men and 7 women aged 24–35 years) with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitsukawa, Tadahiro, Suzuki, Yumi, Momota, Yosuke, Suzuki, Shun, Yamada, Masakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509630/ https://www.ncbi.nlm.nih.gov/pubmed/34640402 http://dx.doi.org/10.3390/jcm10194384

Ejemplares similares

Anterior Segment Biometry During Accommodation and Effects of Cycloplegics by Swept-Source Optical Coherence Tomography
por: Mitsukawa, Tadahiro, et al.
Publicado: (2020)

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

Compounded 0.01% Atropine—What's in the Bottle?
por: Richdale, Kathryn, et al.
Publicado: (2023)

Effectiveness of 0.01% atropine in anisomyopic children
por: Hussain, Azfira, et al.
Publicado: (2023)

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022)

The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
por: Cheng, Ziyun, et al.
Publicado: (2021)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)

Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Jethani, Jitendra, et al.
Publicado: (2020)

Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination
por: Hao, Qian, et al.
Publicado: (2021)

Role of 0.01% atropine in high myopic children of Moradabad, India (RAMCOM Study)
por: Agarwal, Pradeep, et al.
Publicado: (2022)

A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
por: Joachimsen, Lutz, et al.
Publicado: (2019)

Response to comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2020)

Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2022)

Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
por: Tan, Qi, et al.
Publicado: (2023)

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
por: Ye, Luyao, et al.
Publicado: (2022)

Clinical utility of anterior segment swept-source optical coherence tomography in glaucoma
por: Angmo, Dewang, et al.
Publicado: (2016)

Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
por: Tsai, Hou-Ren, et al.
Publicado: (2021)

Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children
por: Jethani, Jitendra, et al.
Publicado: (2021)

Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Short-Term Effects of Atropine 0.01% on the Structure and Vasculature of the Choroid and Retina in Myopic Chinese Children
por: Wang, Yuliang, et al.
Publicado: (2022)

Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022)

Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2023)

The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis
por: Wang, Zengying, et al.
Publicado: (2023)

Segmentation Errors in the Measurement of Volumetric Parameters by Swept-Source Anterior Segment Optical Coherence Tomography
por: Chen, Hailiu, et al.
Publicado: (2021)

Myopia control: short-term effect of 0.01% atropine vs. defocus incorporated multiple segment lenses—a retrospective study in European children
por: Guimarães, Sandra, et al.
Publicado: (2023)

Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
por: Chaurasia, Shweta, et al.
Publicado: (2022)

Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
por: Rose, Loreto V. T., et al.
Publicado: (2021)

Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Patil, Ankita A, et al.
Publicado: (2022)

Swept Source Optical Coherence Tomography Analysis of the Selected Eye’s Anterior Segment Parameters
por: Dembski, Michał, et al.
Publicado: (2021)

Role of swept-source anterior segment optical coherence tomography in imaging pediatric cataract
por: Bhardwaj, Anand, et al.
Publicado: (2023)

Comparative Study of the Effects of 1% Atropine on the Anterior Segment
por: Zhou, Yue, et al.
Publicado: (2020)

Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia
por: Kothari, Mihir, et al.
Publicado: (2020)

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial
por: Cui, Can, et al.
Publicado: (2021)

Response to comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response
por: Chan, Henry H. L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j031t9p30dnd0iog2cg0sclnq2